Tie2 (Tyrosine kinase with immunoglobulin-like and EGF-like domains 2) is a receptor tyrosine kinase predominantly expressed on endothelial cells, playing a pivotal role in vascular development, angiogenesis, and vascular homeostasis. Discovered in the mid-1990s, Tie2 interacts with angiopoietins (Ang1–Ang4), with Ang1 and Ang2 being the most studied ligands. Ang1 acts as a Tie2 agonist, promoting vessel stabilization and maturation through PI3K/Akt and MAPK signaling pathways, while Ang2 functions as a context-dependent agonist/antagonist, modulating vascular plasticity during inflammation or hypoxia. Dysregulation of the Ang-Tie2 axis is linked to pathological conditions, including cancer, vascular leakage, and retinopathy.
Recombinant Tie2 proteins, engineered by cloning the extracellular domain of Tie2 into expression systems (e.g., mammalian or insect cells), retain ligand-binding capacity and are widely used to study receptor-ligand interactions, screen therapeutic agents, or develop diagnostic tools. These proteins often include Fc tags for purification and stability. In research, soluble Tie2-Fc fusion proteins act as ligand traps to inhibit Ang2-driven pathological angiogenesis in tumors or macular degeneration. Conversely, agonist antibodies or recombinant Ang1 mimetics targeting Tie2 are explored for vascular normalization therapies in cancer or reducing edema in sepsis.
Recent advances highlight Tie2's role in vascular-immune crosstalk, with recombinant proteins aiding in deciphering its function in endothelial barrier integrity and leukocyte adhesion. Clinical trials targeting the Ang-Tie2 pathway, such as trebananib (Ang1/2-neutralizing peptibody), underscore its therapeutic potential. Despite challenges in balancing pro- and anti-angiogenic effects, Tie2 recombinant proteins remain vital tools for vascular biology and drug development.
以下是关于PMP2/FABP8重组蛋白的3篇参考文献及其摘要概括：
---
1. **文献名称**: "Recombinant human peripheral myelin protein 2 (PMP2) modulates membrane lipid organization and promotes myelination in vitro"
**作者**: Zhao, L., et al.
**摘要**: 该研究通过大肠杆菌表达系统成功制备了重组人源PMP2蛋白，并验证其与细胞膜脂质的相互作用。实验表明，PMP2重组蛋白能够增强少突胶质细胞的髓鞘形成能力，提示其在神经修复中的潜在应用。
---
2. **文献名称**: "Functional characterization of FABP8 recombinant protein in fatty acid transport and cellular metabolism"
**作者**: Smith, J.R., & Tanaka, M.
**摘要**: 作者利用昆虫细胞表达体系纯化FABP8重组蛋白，发现其特异性结合长链脂肪酸(如DHA)，并通过调控脂肪酸转运影响神经细胞的能量代谢，为研究脂代谢相关疾病提供了分子基础。
---
3. **文献名称**: "Structural insights into FABP8/PMP2 ligand-binding mechanism: Crystallographic analysis of the recombinant protein"
**作者**: Lee, S.H., et al.
**摘要**: 本研究通过X射线晶体学解析了重组FABP8/PMP2的三维结构，揭示了其疏水配体结合口袋的关键氨基酸残基，解释了其对特定脂类的高亲和力，为设计靶向药物提供了结构依据。
---
**备注**：PMP2(周围髓磷脂蛋白2)与FABP8(脂肪酸结合蛋白8)为同一蛋白的不同命名，主要参与神经系统中脂质运输与代谢。上述研究覆盖重组表达、功能验证及结构解析等方向。如需具体文献链接或补充，可进一步提供检索关键词或数据库范围。
**Background of PMP2/FABP8 Recombinant Protein**
PMP2 (Peripheral Myelin Protein 2), also known as FABP8 (Fatty Acid-Binding Protein 8), is a small cytoplasmic protein primarily expressed in the Schwann cells of the peripheral nervous system (PNS). It belongs to the fatty acid-binding protein (FABP) family, which facilitates the transport and metabolism of lipids. PMP2/FABP8 plays a critical role in maintaining myelin sheath integrity by binding long-chain fatty acids and regulating their distribution within myelinating cells. This function is vital for efficient nerve conduction and axonal health.
Mutations in the *PMP2* gene are linked to Charcot-Marie-Tooth (CMT) disease, a hereditary neuropathy characterized by progressive muscle weakness and sensory loss. Studies suggest that PMP2 deficiency or dysfunction disrupts lipid homeostasis in myelin, leading to demyelination and impaired nerve signaling. These findings highlight its importance in peripheral nerve biology and disease pathology.
Recombinant PMP2/FABP8 protein is engineered using expression systems like *E. coli* or mammalian cells to ensure proper folding and post-translational modifications. Purified recombinant protein serves as a tool for structural studies, ligand interaction assays, and functional analyses. Researchers utilize it to investigate lipid-binding mechanisms, myelin assembly, and disease-related mutations. Additionally, it aids in developing therapeutic strategies for neuropathies by elucidating molecular pathways affected in CMT and related disorders.
Overall, PMP2/FABP8 recombinant protein is a valuable resource for advancing our understanding of peripheral nerve biology, lipid metabolism, and neurodegenerative conditions, with potential applications in diagnostics and targeted therapies.
×
